Last chance to take part in AusBiotech’s annual CEO survey
Tuesday, 31 January, 2012
Proudly supported by Grant Thornton, the survey is seeking views on the operating environment and asks questions that will help build evidence about the significance of the industry and its perspectives, as well as tracking trends.
The de-identified results will be released in a comprehensive industry report, to be launched at industry briefings in April. Last year 42 of Australia’s biotechnology companies were named as participants in the report and a further group contributed anonymously.
The information in report was of interest to government representatives, parliamentarians, the media and investors, as well as to the industry itself.
In order for AusBiotech to rally as a cohesive industry body with a common goal, it seeks this information to build a strong platform for campaigning, to better represent the sector with strong statements about the magnitude of issues and trends and what would be likely to redress them.
Enquires about the survey may be directed to AusBiotech’s Communications Manager on lchiroiu@ausbiotech.org or 03 9828 1414.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
